17,261 trials
Human Papilloma Virus Infection · Stage III Squamous Cell Carcinoma of the Oropharynx · Stage IVA Squamous Cell Carcinoma of the Oropharynx
Primary: Progression-Free Survival (PFS), Evaluated Using RECIST Version (v) 1.1 — 94.5 percentage of participants
Non-small Cell Lung Cancer
Primary: Local Failure Free Survival — 9.4; 9.9 months
Diabetes Mellitus, Type 2
Primary: Percentage of Time in Target Range 3.9-10.0 mmol/L (70-180 Milligrams Per Deciliter (mg/dL)) Measured Using CGM (Continuous Glucose Monitoring) — 65.99; 72.86; 64.98…
Colorectal Carcinoma · CRC
Primary: Determine Radiographic Response Rate of Patients Enrolled in the Phase 2a Portion of the Study — 0; 0; 0; 1 Participants
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
Primary: Overall Response Rate — 12 Participants — p=0.044
Familial Chylomicronemia Syndrome · Lipoprotein Lipase Deficiency · Hyperlipoproteinemia Type 1
Primary: Absolute Change From Baseline to Month 3 in Fasting Triglycerides (TG) — -550.00 mg/dL
Stem Cell Transplantation · Leukemia
Primary: Number of Participants With Molecular Response — 8; 0; 4 Participants
Old World Cutaneous Leishmaniasis
Primary: Safety: Overview of Adverse Events — 16; 7; 0; 0 Participants
Wound Healing Disturbance of
Primary: Wound Re-epithelization — 12.34; 10.27; 11.33 days
Intermittent Claudication
Primary: Change in Peak Walking Time (PWT) From Baseline — 5.394; 5.712; 1.121; 1.493 minutes — p=0.727
Hodgkin's Lymphoma
Primary: Maximum Tolerated Dose (MTD) of Panobinostat + ICE — 30 mg
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Primary: Change From Baseline in Alanine Aminotransferase (ALT) at Week 12 — -22.06; -30.41; -8.77 Units per Liter (U/L) — p=0.075
Dry Eye Syndromes · Keratoconjunctivitis Sicca
Primary: Bulbar Conjunctival Hyperemia — 1.22; 1.36 score on a scale
Chronic Hepatitis B
Primary: Percentage of Participants With ≥ 1 log10 IU/mL Decline in Serum Quantitative Hepatitis B Surface Antigen (qHBsAg) From Baseline at Week 24 — 0; 0; 0 percentage of…
Trichuriasis · Hookworm Infections
Primary: Cure Rate Against T. Trichiura and Hookworm Infections — 4; 2; 4; 5 Participants